Rhenman & Partners Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Rhenman & Partners Asset Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.85M	Sell	81,627 -17,000	-17%	-$984K	0.85%	49
2025 Q4	$4.06M	Sell	98,627 -75,000	-43%	-$2.91M	0.38%	69
2025 Q3	$6.83M	Buy	173,627 +47,000	+37%	+$1.2M	0.76%	45
2025 Q2	$2.36M	Hold	126,627	–	–	0.3%	68
2025 Q1	$2.3M	Buy	126,627 +12,627	+11%	+$278K	0.26%	67
2024 Q4	$2.49M	Sell	114,000 -36,000	-24%	-$926K	0.26%	75
2024 Q3	$4.11M	Buy	+150,000	New	+$4.18M	0.33%	68

Other funds holding DNTH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return